Onex Canada Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-10,000
| Closed | -$24K | – | 182 |
|
2021
Q1 | $24K | Hold |
10,000
| – | – | ﹤0.01% | 205 |
|
2020
Q4 | $18K | Hold |
10,000
| – | – | ﹤0.01% | 133 |
|
2020
Q3 | $9K | Hold |
10,000
| – | – | ﹤0.01% | 135 |
|
2020
Q2 | $9K | Hold |
10,000
| – | – | ﹤0.01% | 131 |
|
2020
Q1 | $8K | Hold |
10,000
| – | – | ﹤0.01% | 134 |
|
2019
Q4 | $9K | Hold |
10,000
| – | – | ﹤0.01% | 130 |
|
2019
Q3 | $10K | Hold |
10,000
| – | – | ﹤0.01% | 122 |
|
2019
Q2 | $11K | Hold |
10,000
| – | – | ﹤0.01% | 120 |
|
2019
Q1 | $13K | Hold |
10,000
| – | – | ﹤0.01% | 113 |
|
2018
Q4 | $9K | Sell |
10,000
-1,430
| -13% | -$1.29K | ﹤0.01% | 98 |
|
2018
Q3 | $23K | Hold |
11,430
| – | – | ﹤0.01% | 103 |
|
2018
Q2 | $21K | Sell |
11,430
-2,057
| -15% | -$3.78K | ﹤0.01% | 97 |
|
2018
Q1 | $32K | Hold |
13,487
| – | – | ﹤0.01% | 86 |
|
2017
Q4 | $25K | Hold |
13,487
| – | – | ﹤0.01% | 93 |
|
2017
Q3 | $34K | Hold |
13,487
| – | – | ﹤0.01% | 63 |
|
2017
Q2 | $37K | Hold |
13,487
| – | – | ﹤0.01% | 93 |
|
2017
Q1 | $41K | Hold |
13,487
| – | – | ﹤0.01% | 81 |
|
2016
Q4 | $43K | Hold |
13,487
| – | – | ﹤0.01% | 87 |
|
2016
Q3 | $45K | Hold |
13,487
| – | – | ﹤0.01% | 82 |
|
2016
Q2 | $31K | Hold |
13,487
| – | – | ﹤0.01% | 87 |
|
2016
Q1 | $34K | Sell |
13,487
-1,133
| -8% | -$2.86K | ﹤0.01% | 94 |
|
2015
Q4 | $48K | Buy |
+14,620
| New | +$48K | ﹤0.01% | 85 |
|